Emergence Of New Myeloma Drugs, And Combinations, Raises Red Flag On Costs
Combinations of two or more branded drugs likely mean better potency and sales across the board, but mounting costs are likely to raise red flag with payers.
Combinations of two or more branded drugs likely mean better potency and sales across the board, but mounting costs are likely to raise red flag with payers.